Nonprofit systems Advocate Aurora Health, Atrium Health announce $27B, 67-hospital merger CSL's $11.7B Vifor buy, 2021's biggest biopharma M&A deal, hits antitrust delay As Siemens AG leaves Russia over Ukraine war, Siemens Healthineers will stay Bristol Myers provides Bridge over troubled water with $905M deal to enter SHP2 race AMA, AHA among groups pressing HHS to keep COVID-19 emergency past July expiration date Pfizer partner Biovac warns of production slump amid low COVID vaccine demand: report Caribou ready to uncork the chardonnay thanks to first-in-human CAR-T results GE Healthcare aims to bring prenatal ultrasound to the home, with investment in smartphone-scanner developer Ready to go to FDA, can Hengrui's China-made PD-1 liver cancer immunotherapy change the tides? Witty: UnitedHealth bullish on its growth trajectory, particularly for Optum Paige nets European OK for AI to spot prostate cancer biomarkers Human Cell Atlas initiative makes strides as scientists piece together 'Google Map' of human cells Mammogram-reading AI developer Therapixel snags €15M to expand US presence Featured Story | By Dave Muoio Under the new brand of Advocate Health, the joint system would serve about 5.5 million patients, operate over 1,000 care sites and employ 148,000 people. read more |
| |
|---|
|
Top Stories By Angus Liu Australian biotech CSL said (PDF) the regulatory review of its $11.7 billion acquisition of Switzerland’s Vifor Pharma will take “a few more months,” suggesting it won’t be able to close the transaction by June 2022 as previously expected. Vifor said some antitrust authorities haven’t delivered a verdict. read more By Conor Hale Siemens AG’s decision to exit Russia does not include Siemens Healthineers, according to the company, which previously said it would continue to support healthcare providers and patients in the country. read more By Nick Paul Taylor Bristol Myers Squibb came to the rescue of a beleaguered BridgeBio today, striking a $905 million biobuck deal to secure a rival to oncology candidates in development at Merck, Novartis, Roche, Sanofi and more. read more By Robert King Major provider groups are pressing HHS to continue the COVID-19 public health emergency, which could expire in July and erase key regulatory flexibilities for doctors and hospitals. read more By Fraiser Kansteiner Following similar proclamations from the Serum Institute of India and Aspen Pharmacare, Pfizer-partnered Biovac is the latest pandemic vaccine manufacturer to forecast possible production shortfalls amid a slump in global demand. read more By Annalee Armstrong At Caribou Biosciences’ upcoming 10th birthday party celebration, the chardonnay will be flowing. That’s because the biotech is uncorking first-in-human data for its CAR-T cell therapy that CEO Rachel Haurwitz believes are better than the three approved lymphoma treatments in the class. read more By Conor Hale Pulsenmore’s device docks with a smartphone, allowing women to conduct their own exams and potentially skip an in-person doctor’s visit. read more By Angus Liu After two FDA rejections against China-made cancer immunotherapies this year, another Chinese pharma major hopes it has the data to crack the agency’s doors open in liver cancer. But one major uncertainty remains. read more By Paige Minemyer Executives said Wednesday at the BofA Securities Healthcare Conference that they're confident that the company will continue to meet its double-digit growth targets even as it continues to expand. read more By Andrea Park With the new tool, Paige is aiming to make biomarker detection more accessible and more widely used in cancer diagnostics. read more By Angus Liu The Human Cell Atlas consortium has added important pieces to the creation of the full map of human cells, offering new insights into gene activity in specific cell types and how immune cells behave in various human tissues and organs. read more By Andrea Park To make MammoScreen more ubiquitous in cancer screening across the U.S., Therapixel plans to add new features and ramp up its sales and commercial activities in the region. read more |
